Drug · DIN 02415534
DUREZOL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since April 20, 2018; first marketed February 19, 2014.
- Drug Identification Number (DIN)
- 02415534
- Company (DIN owner)
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Emulsion
- Route
- Ophthalmic
- Therapeutic class (ATC)
- Corticosteroids, plain S01BA
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DIFLUPREDNATE | 0.05 % | W/V |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 16, 2017: NOC 19068New Drug Submission (NDS) · Administrative: Transfer of Drug Identification Number
- November 4, 2013: NOC 14876New Drug Submission (NDS)